HomeClinical ToolsRefeeding syndrome

⚠️ Refeeding Syndrome Risk (NICE)

This tool applies the NICE criteria to determine high or extremely-high risk of refeeding syndrome and to guide safe feeding initiation and electrolyte monitoring.

Clinical takeaway

Feeding is never delayed to correct electrolytes — potassium, phosphate, and magnesium are replaced concurrently. (original synthesis · not guideline verbatim)

Loading calculator…
Share on XLinkedInWhatsAppEmail

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

When to use

Use to classify risk and set the starting calorie rate, thiamine supplementation, and electrolyte monitoring before and during refeeding.

How it works

High risk = ≥ 1 major (BMI < 16, loss > 15%, minimal intake > 10 days, low pre-feeding K/PO4/Mg) or ≥ 2 minor criteria. Extremely high = BMI < 14 or near-no intake > 15 days. Start 10 kcal/kg/d (extreme 5), thiamine first.

Key points

  • Feeding is never delayed to correct electrolytes — potassium, phosphate, and magnesium are replaced concurrently. (original synthesis · not guideline verbatim)
  • Thiamine is given before feeding and through the first 10 days to prevent Wernicke encephalopathy.
  • Extremely high risk starts at just 5 kcal/kg/d with cardiac monitoring.

References

Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

BMI≥ 18.5 (0)
Unintentional weight loss (3–6 months)< 10% (0)
Intake/feeding statusLargely normal (0)
Pre-feeding K/phosphate/magnesiumNormal (0)
Alcohol use history or relevant drugs (insulin/chemotherapy/antacids/diuretics)None (0)

Refeeding riskDoes not meet high-risk criteria (still assess individually)

  • Determination0 major criteria, 0 minor criteria → Does not meet high-risk criteria (still assess individually) (≥ 1 major or ≥ 2 minor = high risk)
  • Feeding initiationAdvance per routine nutrition support, with attention to monitoring
  • VitaminsSupplement thiamine (vitamin B1) and a B-complex/multivitamin before feeding and for the first 10 days
BMI< 14 (extremely high risk)
Unintentional weight loss (3–6 months)> 15% (major)
Intake/feeding statusAlmost none > 15 days (extremely high risk)
Pre-feeding K/phosphate/magnesiumLow (major)
Alcohol use history or relevant drugs (insulin/chemotherapy/antacids/diuretics)Present (minor)

Refeeding riskExtremely high risk

  • Determination2 major criteria, 1 minor criteria, including an extremely-high-risk criterion → Extremely high risk (≥ 1 major or ≥ 2 minor = high risk)
  • Feeding initiationExtremely high risk: start at 5 kcal/kg/d, increase gradually, close monitoring (cardiac monitoring)
  • VitaminsSupplement thiamine (vitamin B1) and a B-complex/multivitamin before feeding and for the first 10 days

Frequently asked questions

What is Refeeding Syndrome Risk (NICE)?
This tool applies the NICE criteria to determine high or extremely-high risk of refeeding syndrome and to guide safe feeding initiation and electrolyte monitoring.
How is Refeeding Syndrome Risk (NICE) calculated? What is the core formula?
High risk = ≥ 1 major (BMI < 16, loss > 15%, minimal intake > 10 days, low pre-feeding K/PO4/Mg) or ≥ 2 minor criteria. Extremely high = BMI < 14 or near-no intake > 15 days. Start 10 kcal/kg/d (extreme 5), thiamine first.
When is Refeeding Syndrome Risk (NICE) used?
Use to classify risk and set the starting calorie rate, thiamine supplementation, and electrolyte monitoring before and during refeeding.
What are the key clinical points for Refeeding Syndrome Risk (NICE)?
Feeding is never delayed to correct electrolytes — potassium, phosphate, and magnesium are replaced concurrently. (original synthesis · not guideline verbatim) Thiamine is given before feeding and through the first 10 days to prevent Wernicke encephalopathy. Extremely high risk starts at just 5 kcal/kg/d with cardiac monitoring.
What are the limits and cautions when using Refeeding Syndrome Risk (NICE)?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
How is Refeeding Syndrome Risk (NICE) calculated in practice? Can you show a worked example?
Inputs: BMI ≥ 18.5 (0), Unintentional weight loss (3–6 months) < 10% (0), Intake/feeding status Largely normal (0), Pre-feeding K/phosphate/magnesium Normal (0), Alcohol use history or relevant drugs (insulin/chemotherapy/antacids/diuretics) None (0) → Result: Refeeding risk Does not meet high-risk criteria (still assess individually)(Determination: 0 major criteria, 0 minor criteria → Does not meet high-risk criteria (still assess individually) (≥ 1 major or ≥ 2 minor = high risk), Feeding initiation: Advance per routine nutrition support, with attention to monitoring, Vitamins: Supplement thiamine (vitamin B1) and a B-complex/multivitamin before feeding and for the first 10 days) Inputs: BMI < 14 (extremely high risk), Unintentional weight loss (3–6 months) > 15% (major), Intake/feeding status Almost none > 15 days (extremely high risk), Pre-feeding K/phosphate/magnesium Low (major), Alcohol use history or relevant drugs (insulin/chemotherapy/antacids/diuretics) Present (minor) → Result: Refeeding risk Extremely high risk(Determination: 2 major criteria, 1 minor criteria, including an extremely-high-risk criterion → Extremely high risk (≥ 1 major or ≥ 2 minor = high risk), Feeding initiation: Extremely high risk: start at 5 kcal/kg/d, increase gradually, close monitoring (cardiac monitoring), Vitamins: Supplement thiamine (vitamin B1) and a B-complex/multivitamin before feeding and for the first 10 days)

Other tools

🚨 Sepsis Bundle💧 DKA/HHS🚑 Anaphylaxis Management🫁 ARDSnet lung-protective ventilation

中文版 →